chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Acute pulmonary oedema, COVID-19, Cardiac failure acute, Cardiac failure congestive, Chest X-ray abnormal
Clinical narrative: Discharge Provider: PRIVATE, MD Primary Care Provider: PRIVATE, MD Admission Date: 12/11/2022 Discharge Date: Dec 16, 2022 COVID positive Date 12/11/2022  PRESENTING PROBLEM: Flash pulmonary edema (HCC) [J81.0] Hypoxia [R09.02] Acute on chronic congestive heart failure, unspecified heart failure type (HCC) [I50.9]   HOSPITAL COURSE: Patient is a 88 y.o. female with past medical history of chronic diastolic CHF, Crohn's disease, CKD stage IIIA, permanent atrial fibrillation on Xarelto, hyperthyroidism and pulmonary hypertension who presented with shortness of breath. She was brought in by EMS and in the ER was found to have COVID-19, CXR with pulmonary edema, and started on HFNC and Lasix. She was admitted to medicine for further evaluation.    Oxygen was able to wean down to nasal cannula. Continued on steroids while on oxygen. Continued Lasix to diurese. She underwent TTE to further evaluate which showed a newly decreased EF to 43% with minor RWMA. Cardiology was consulted. She underwent a Lexiscan which showed no myocardial ischemia, and return of EF to normal. Lasix was switch to oral dosing.   On initial CXR in ER there was note of a thyroid mass with unclear nature. A CT thorax was completed to further evaluate this and showed a goiter that is causing mass effect on the trachea. This is a chronic problem the patient is well aware of. She follows closely with Dr. (Endocrinology) to monitor this and wants to avoid further interventions if possible. She was in stable condition and discharged home on 12/16/2022.
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Computerised tomogram thorax abnormal, Condition aggravated, Dyspnoea, Echocardiogram, Ejection fraction decreased
Clinical narrative: Discharge Provider: PRIVATE, MD Primary Care Provider: PRIVATE, MD Admission Date: 12/11/2022 Discharge Date: Dec 16, 2022 COVID positive Date 12/11/2022  PRESENTING PROBLEM: Flash pulmonary edema (HCC) [J81.0] Hypoxia [R09.02] Acute on chronic congestive heart failure, unspecified heart failure type (HCC) [I50.9]   HOSPITAL COURSE: Patient is a 88 y.o. female with past medical history of chronic diastolic CHF, Crohn's disease, CKD stage IIIA, permanent atrial fibrillation on Xarelto, hyperthyroidism and pulmonary hypertension who presented with shortness of breath. She was brought in by EMS and in the ER was found to have COVID-19, CXR with pulmonary edema, and started on HFNC and Lasix. She was admitted to medicine for further evaluation.    Oxygen was able to wean down to nasal cannula. Continued on steroids while on oxygen. Continued Lasix to diurese. She underwent TTE to further evaluate which showed a newly decreased EF to 43% with minor RWMA. Cardiology was consulted. She underwent a Lexiscan which showed no myocardial ischemia, and return of EF to normal. Lasix was switch to oral dosing.   On initial CXR in ER there was note of a thyroid mass with unclear nature. A CT thorax was completed to further evaluate this and showed a goiter that is causing mass effect on the trachea. This is a chronic problem the patient is well aware of. She follows closely with Dr. (Endocrinology) to monitor this and wants to avoid further interventions if possible. She was in stable condition and discharged home on 12/16/2022.
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Goitre, Hypoxia, Pulmonary oedema, SARS-CoV-2 test positive, Scan myocardial perfusion normal
Clinical narrative: Discharge Provider: PRIVATE, MD Primary Care Provider: PRIVATE, MD Admission Date: 12/11/2022 Discharge Date: Dec 16, 2022 COVID positive Date 12/11/2022  PRESENTING PROBLEM: Flash pulmonary edema (HCC) [J81.0] Hypoxia [R09.02] Acute on chronic congestive heart failure, unspecified heart failure type (HCC) [I50.9]   HOSPITAL COURSE: Patient is a 88 y.o. female with past medical history of chronic diastolic CHF, Crohn's disease, CKD stage IIIA, permanent atrial fibrillation on Xarelto, hyperthyroidism and pulmonary hypertension who presented with shortness of breath. She was brought in by EMS and in the ER was found to have COVID-19, CXR with pulmonary edema, and started on HFNC and Lasix. She was admitted to medicine for further evaluation.    Oxygen was able to wean down to nasal cannula. Continued on steroids while on oxygen. Continued Lasix to diurese. She underwent TTE to further evaluate which showed a newly decreased EF to 43% with minor RWMA. Cardiology was consulted. She underwent a Lexiscan which showed no myocardial ischemia, and return of EF to normal. Lasix was switch to oral dosing.   On initial CXR in ER there was note of a thyroid mass with unclear nature. A CT thorax was completed to further evaluate this and showed a goiter that is causing mass effect on the trachea. This is a chronic problem the patient is well aware of. She follows closely with Dr. (Endocrinology) to monitor this and wants to avoid further interventions if possible. She was in stable condition and discharged home on 12/16/2022.
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Thyroid mass, Tracheal disorder, Wall motion score index abnormal
Clinical narrative: Discharge Provider: PRIVATE, MD Primary Care Provider: PRIVATE, MD Admission Date: 12/11/2022 Discharge Date: Dec 16, 2022 COVID positive Date 12/11/2022  PRESENTING PROBLEM: Flash pulmonary edema (HCC) [J81.0] Hypoxia [R09.02] Acute on chronic congestive heart failure, unspecified heart failure type (HCC) [I50.9]   HOSPITAL COURSE: Patient is a 88 y.o. female with past medical history of chronic diastolic CHF, Crohn's disease, CKD stage IIIA, permanent atrial fibrillation on Xarelto, hyperthyroidism and pulmonary hypertension who presented with shortness of breath. She was brought in by EMS and in the ER was found to have COVID-19, CXR with pulmonary edema, and started on HFNC and Lasix. She was admitted to medicine for further evaluation.    Oxygen was able to wean down to nasal cannula. Continued on steroids while on oxygen. Continued Lasix to diurese. She underwent TTE to further evaluate which showed a newly decreased EF to 43% with minor RWMA. Cardiology was consulted. She underwent a Lexiscan which showed no myocardial ischemia, and return of EF to normal. Lasix was switch to oral dosing.   On initial CXR in ER there was note of a thyroid mass with unclear nature. A CT thorax was completed to further evaluate this and showed a goiter that is causing mass effect on the trachea. This is a chronic problem the patient is well aware of. She follows closely with Dr. (Endocrinology) to monitor this and wants to avoid further interventions if possible. She was in stable condition and discharged home on 12/16/2022.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: Body pain
Age: 30.0
Sex: M
Vaccine: COVID19-2
Symptoms: No adverse event, Underdose
Clinical narrative: Patient who is an adult was given 0.25mL of the Moderna Bivalent COVID booster vaccine, which is less than the authorized dose of 0.50mL.  No adverse events were noted at the time of the administration.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Atrial fibrillation, Dizziness, Heart rate irregular, Hypertension, Nausea
Clinical narrative: Woke up with very high blood pressure, racing pulse, a bit of afib, nausea and dizziness; I thought I was having a heart attack, so I went to the emergency
Age: 34.0
Sex: F
Vaccine: COVID19-2
Symptoms: Chills, Diarrhoea, Dysgeusia, Fatigue, Headache
Clinical narrative: Metal taste in the mouth, sweating, headache, palpitations and heavy legs few minutes after the shot.  Two hours after I was just feeling chills, low fever, headache, diarrhea, tiredness and pain in the local of the shot (mild to moderate).
Age: 34.0
Sex: F
Vaccine: COVID19-2
Symptoms: Hyperhidrosis, Injection site pain, Limb discomfort, Palpitations, Pyrexia
Clinical narrative: Metal taste in the mouth, sweating, headache, palpitations and heavy legs few minutes after the shot.  Two hours after I was just feeling chills, low fever, headache, diarrhea, tiredness and pain in the local of the shot (mild to moderate).
Age: 73.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: Opened Moderna Bivalent Booster at 9:10 am on 12/19/22. Old drawn up ones were not throw away and one expired one was used accidentally today at 12/20/22 at 10:00 am. Patient has not had any bad reactions.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Dyspnoea, Pneumonia, Tachycardia, Tachypnoea
Clinical narrative: Patient was brought to the ED with tachycardia and tachypneic and short of breath.  No fever, chills, or cough.  Patient was admitted to the hospital with Covid and pneumonia and treated with 3 doses of remdesivir.
Age: 51.0
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: Patient was given Pfizer COVID-19 bivalent vaccine as first dose in series. No adverse reaction has been reported by patient.
Age: 50.0
Sex: M
Vaccine: COVID19, FLU4
Symptoms: Alanine aminotransferase increased, Aspartate aminotransferase increased, Asthenia, Blood sodium decreased, COVID-19
Clinical narrative: Discharge Provider: PRIVATE, MD Primary Care Provider: PRIVATE, DO Admission Date: 12/11/2022 Discharge Date: Dec 16, 2022 COVID positive Date: 12/11/2022  PRESENTING PROBLEM: Hyponatremia [E87.1] Hypotension, unspecified hypotension type [I95.9] COVID-19 [U07.1]   HOSPITAL COURSE:   Patient is a 51-year-old male with history of type 2 diabetes mellitus, hypothyroidism and hyperlipidemia who presented with generalized weakness and fatigue for 2-3 days.  In the emergency department, he had mild hypotension.  Labs were significant for sodium of 125, AST 66 an ALT of 72. He tested positive for COVID-19.  Chest x-ray was unremarkable.  He was given 2 L of normal saline and admitted to the hospitalist service for further care.   Upon admit was continued on IV normal saline. He did develop hyperkalemia, hypomagnesemia and hypocalcemia.  His hyperkalemia improved without intervention, but he was supplemented with IV calcium and magnesium with improvement.  His sodium levels improved with normal saline infusion and rehydration.  He had ongoing diarrhea, which was treated symptomatically with Imodium.  This was felt to be secondary to COVID-19 infection.  He had minimal respiratory symptoms, and remained stable on room air.  He did not meet criteria for treatment with IV remdesivir or oral Decadron. Pt on day of discharge reports feeling well. Diarrhea resolved and he has been tolerating PO foods >48 hrs. Discharged on 12/16 with sodium tabs x3 d. Will have follow up with PCP in 1 week.
Age: 50.0
Sex: M
Vaccine: COVID19, FLU4
Symptoms: Chest X-ray normal, Diarrhoea, Fatigue, Hyperkalaemia, Hypocalcaemia
Clinical narrative: Discharge Provider: PRIVATE, MD Primary Care Provider: PRIVATE, DO Admission Date: 12/11/2022 Discharge Date: Dec 16, 2022 COVID positive Date: 12/11/2022  PRESENTING PROBLEM: Hyponatremia [E87.1] Hypotension, unspecified hypotension type [I95.9] COVID-19 [U07.1]   HOSPITAL COURSE:   Patient is a 51-year-old male with history of type 2 diabetes mellitus, hypothyroidism and hyperlipidemia who presented with generalized weakness and fatigue for 2-3 days.  In the emergency department, he had mild hypotension.  Labs were significant for sodium of 125, AST 66 an ALT of 72. He tested positive for COVID-19.  Chest x-ray was unremarkable.  He was given 2 L of normal saline and admitted to the hospitalist service for further care.   Upon admit was continued on IV normal saline. He did develop hyperkalemia, hypomagnesemia and hypocalcemia.  His hyperkalemia improved without intervention, but he was supplemented with IV calcium and magnesium with improvement.  His sodium levels improved with normal saline infusion and rehydration.  He had ongoing diarrhea, which was treated symptomatically with Imodium.  This was felt to be secondary to COVID-19 infection.  He had minimal respiratory symptoms, and remained stable on room air.  He did not meet criteria for treatment with IV remdesivir or oral Decadron. Pt on day of discharge reports feeling well. Diarrhea resolved and he has been tolerating PO foods >48 hrs. Discharged on 12/16 with sodium tabs x3 d. Will have follow up with PCP in 1 week.
Age: 50.0
Sex: M
Vaccine: COVID19, FLU4
Symptoms: Hypomagnesaemia, Hyponatraemia, Hypotension, Mineral supplementation, SARS-CoV-2 test positive
Clinical narrative: Discharge Provider: PRIVATE, MD Primary Care Provider: PRIVATE, DO Admission Date: 12/11/2022 Discharge Date: Dec 16, 2022 COVID positive Date: 12/11/2022  PRESENTING PROBLEM: Hyponatremia [E87.1] Hypotension, unspecified hypotension type [I95.9] COVID-19 [U07.1]   HOSPITAL COURSE:   Patient is a 51-year-old male with history of type 2 diabetes mellitus, hypothyroidism and hyperlipidemia who presented with generalized weakness and fatigue for 2-3 days.  In the emergency department, he had mild hypotension.  Labs were significant for sodium of 125, AST 66 an ALT of 72. He tested positive for COVID-19.  Chest x-ray was unremarkable.  He was given 2 L of normal saline and admitted to the hospitalist service for further care.   Upon admit was continued on IV normal saline. He did develop hyperkalemia, hypomagnesemia and hypocalcemia.  His hyperkalemia improved without intervention, but he was supplemented with IV calcium and magnesium with improvement.  His sodium levels improved with normal saline infusion and rehydration.  He had ongoing diarrhea, which was treated symptomatically with Imodium.  This was felt to be secondary to COVID-19 infection.  He had minimal respiratory symptoms, and remained stable on room air.  He did not meet criteria for treatment with IV remdesivir or oral Decadron. Pt on day of discharge reports feeling well. Diarrhea resolved and he has been tolerating PO foods >48 hrs. Discharged on 12/16 with sodium tabs x3 d. Will have follow up with PCP in 1 week.
Age: 76.0
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect dose administered, Product preparation issue
Clinical narrative: patient was given pediatric dose without diluting 0.3ml, spoke to md and they are fine.
Age: 37.0
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: Pfizer Bivalent given inadvertently the patient had not had initial Monovalent vaccine.  No adverse reaction occurred.
Age: 10.0
Sex: M
Vaccine: DTAPIPV, HEPA
Symptoms: Circumstance or information capable of leading to medication error, Extra dose administered, Wrong product administered
Clinical narrative: 2 siblings have well child check appts (10 yrs and 4 yrs), both were very nervous and moving around during vaccination time. Mother of child did really good job by holding them, but still both were really afraid and moving a lot. I grabbed the wrong tray of vaccines, I had 2, but still grabbed the wrong one. Mother of child saw and said, "I think you bragged the wrong tray" "I think that one is for my 4 yrs child." Once I notice I stopped and explained MOC about the incident. Explained technically patient got extra vaccines today and it wont hurt patient. Explained will speak with Dr about this incident. MOC did not argue, states agree and continue to vaccine patient.
Age: 68.0
Sex: M
Vaccine: COVID19-2
Symptoms: COVID-19, Cough, Malaise, SARS-CoV-2 test negative, SARS-CoV-2 test positive
Clinical narrative: I did not have a reaction to the vaccine. On 10/28/2022, I began not feeling well with a dry cough. On 10/30/2022, I was not feeling well and decided to take a COVID-19 test and it was positive. I contacted my doctor and was given the prescription PAXLOVID. I tested negative on 11/07/2022. I rebound and tested positive on 11/11/2022 and tested negative again on 11/13/2022.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Blood test, Chest discomfort, Computerised tomogram, Costochondritis
Clinical narrative: Pericarditis, Costochondritis,  heart palpitations, tingling down left arm and left leg, chest pain, neck pain,  throat tightening, chest tightening, rib pain, headaches for months, neurology eye issues, vertigo,  panic attacks, and anxiety.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Echocardiogram, Eye disorder, Headache, Magnetic resonance imaging, Musculoskeletal chest pain
Clinical narrative: Pericarditis, Costochondritis,  heart palpitations, tingling down left arm and left leg, chest pain, neck pain,  throat tightening, chest tightening, rib pain, headaches for months, neurology eye issues, vertigo,  panic attacks, and anxiety.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Neck pain, Palpitations, Panic attack, Paraesthesia, Pericarditis
Clinical narrative: Pericarditis, Costochondritis,  heart palpitations, tingling down left arm and left leg, chest pain, neck pain,  throat tightening, chest tightening, rib pain, headaches for months, neurology eye issues, vertigo,  panic attacks, and anxiety.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Ultrasound scan, Vertigo
Clinical narrative: Pericarditis, Costochondritis,  heart palpitations, tingling down left arm and left leg, chest pain, neck pain,  throat tightening, chest tightening, rib pain, headaches for months, neurology eye issues, vertigo,  panic attacks, and anxiety.
Age: 56.0
Sex: U
Vaccine: COVID19-2
Symptoms: Tinnitus
Clinical narrative: Worsening Tinnitus.  Never had Tinnitus until first set of Covid 10 Pfiser vaccine but gut worse after booster
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Dyspnoea
Clinical narrative: Patient came to ED with worsening symptoms of  cough and shortness of breath with Covid.  Patient was admitted to the hospital with Covid and treated with remdesivir.
Age: 3.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Pt received Covid vaccine BUD. Vaccine expired on 07/07/22 and was given to pt on 7/19/22
Age: 56.0
Sex: F
Vaccine: COVID19-2, UNK
Symptoms: COVID-19, Chills, Cough, Ear pain, Headache
Clinical narrative: I was experiencing left ear pain. I called the nurse line, and she suggested I go in to make sure I didn't have an ear infection on top of COVID-19. It was not an ear infection. The doctor prescribed Paxlovid. I didn't pick the Paxlovid up until December 19, 2022. The cough, sore throat, fever and chills at night, headache, and sinus pressure has persisted for five days at least.
Age: 56.0
Sex: F
Vaccine: COVID19-2, UNK
Symptoms: Oropharyngeal pain, Paranasal sinus discomfort, Pyrexia
Clinical narrative: I was experiencing left ear pain. I called the nurse line, and she suggested I go in to make sure I didn't have an ear infection on top of COVID-19. It was not an ear infection. The doctor prescribed Paxlovid. I didn't pick the Paxlovid up until December 19, 2022. The cough, sore throat, fever and chills at night, headache, and sinus pressure has persisted for five days at least.
Age: 65.0
Sex: M
Vaccine: COVID19-2
Symptoms: Adult failure to thrive, Agitation, Asthenia, Blood glucose decreased, Blood glucose increased
Clinical narrative: Discharge Provider: MD Primary Care Provider: DO Admission Date: 12/11/2022 Discharge Date: Dec 14, 2022 COVID positive Date 12/12/2022 PRESENTING PROBLEM: Weakness [R53.1] Failure to thrive in adult [R62.7] Low blood glucose measurement [E16.2] COVID-19 [U07.1]   HOSPITAL COURSE: Patient is a 65-year-old male with a past medical history of coronary artery disease s/p PCI in 2019, pulmonary embolism, T2 Diabetes, diabetic neuropathy, Parkinson's disease, stage 3 chronic kidney disease, GERD who presented from an outside living facility after episodes of hypoglycemia and a witnessed fall without loss of consciousness.   On arrival to the emergency department, he was found to be febrile with a temperature of 38.3°.  Glucose was low at 66, left otherwise within normal limits.  He was without leukocytosis.  Imaging, including pelvis x-ray, chest x-ray, and head CT were negative without any signs of acute abnormalities. On routine screening he was found to be positive for COVID, and was subsequently admitted to medicine for management of hypoglycemia in the setting of COVID infection.   Patient's hypoglycemia was thought to be due to poor oral intake, and he was started on a D5 LR infusion.  After approximately 12 hours, his blood sugars normalized in the mid 150s to 200s, and the infusion was subsequently stopped.  Patient did have intermittent episodes of confusion and hallucinations throughout his hospital stay.  Spoke with patient's son, who requested discontinuation of Artane, who stated he had given patient hallucinations and confusion in the past.  Despite discontinuation, patient continued to have persistent episodes of confusion, agitation, and hallucination.  He received p.r.n. Seroquel during these episodes.  It was arranged for him to return to his care facility despite his COVID 19 positive status, and he was subsequently discharged with plans for PCP and neurology follow-up.
Age: 65.0
Sex: M
Vaccine: COVID19-2
Symptoms: COVID-19, Chest X-ray normal, Computerised tomogram head normal, Confusional state, Fall
Clinical narrative: Discharge Provider: MD Primary Care Provider: DO Admission Date: 12/11/2022 Discharge Date: Dec 14, 2022 COVID positive Date 12/12/2022 PRESENTING PROBLEM: Weakness [R53.1] Failure to thrive in adult [R62.7] Low blood glucose measurement [E16.2] COVID-19 [U07.1]   HOSPITAL COURSE: Patient is a 65-year-old male with a past medical history of coronary artery disease s/p PCI in 2019, pulmonary embolism, T2 Diabetes, diabetic neuropathy, Parkinson's disease, stage 3 chronic kidney disease, GERD who presented from an outside living facility after episodes of hypoglycemia and a witnessed fall without loss of consciousness.   On arrival to the emergency department, he was found to be febrile with a temperature of 38.3°.  Glucose was low at 66, left otherwise within normal limits.  He was without leukocytosis.  Imaging, including pelvis x-ray, chest x-ray, and head CT were negative without any signs of acute abnormalities. On routine screening he was found to be positive for COVID, and was subsequently admitted to medicine for management of hypoglycemia in the setting of COVID infection.   Patient's hypoglycemia was thought to be due to poor oral intake, and he was started on a D5 LR infusion.  After approximately 12 hours, his blood sugars normalized in the mid 150s to 200s, and the infusion was subsequently stopped.  Patient did have intermittent episodes of confusion and hallucinations throughout his hospital stay.  Spoke with patient's son, who requested discontinuation of Artane, who stated he had given patient hallucinations and confusion in the past.  Despite discontinuation, patient continued to have persistent episodes of confusion, agitation, and hallucination.  He received p.r.n. Seroquel during these episodes.  It was arranged for him to return to his care facility despite his COVID 19 positive status, and he was subsequently discharged with plans for PCP and neurology follow-up.
Age: 65.0
Sex: M
Vaccine: COVID19-2
Symptoms: Hallucination, Hypoglycaemia, Hypophagia, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Discharge Provider: MD Primary Care Provider: DO Admission Date: 12/11/2022 Discharge Date: Dec 14, 2022 COVID positive Date 12/12/2022 PRESENTING PROBLEM: Weakness [R53.1] Failure to thrive in adult [R62.7] Low blood glucose measurement [E16.2] COVID-19 [U07.1]   HOSPITAL COURSE: Patient is a 65-year-old male with a past medical history of coronary artery disease s/p PCI in 2019, pulmonary embolism, T2 Diabetes, diabetic neuropathy, Parkinson's disease, stage 3 chronic kidney disease, GERD who presented from an outside living facility after episodes of hypoglycemia and a witnessed fall without loss of consciousness.   On arrival to the emergency department, he was found to be febrile with a temperature of 38.3°.  Glucose was low at 66, left otherwise within normal limits.  He was without leukocytosis.  Imaging, including pelvis x-ray, chest x-ray, and head CT were negative without any signs of acute abnormalities. On routine screening he was found to be positive for COVID, and was subsequently admitted to medicine for management of hypoglycemia in the setting of COVID infection.   Patient's hypoglycemia was thought to be due to poor oral intake, and he was started on a D5 LR infusion.  After approximately 12 hours, his blood sugars normalized in the mid 150s to 200s, and the infusion was subsequently stopped.  Patient did have intermittent episodes of confusion and hallucinations throughout his hospital stay.  Spoke with patient's son, who requested discontinuation of Artane, who stated he had given patient hallucinations and confusion in the past.  Despite discontinuation, patient continued to have persistent episodes of confusion, agitation, and hallucination.  He received p.r.n. Seroquel during these episodes.  It was arranged for him to return to his care facility despite his COVID 19 positive status, and he was subsequently discharged with plans for PCP and neurology follow-up.
Age: 65.0
Sex: M
Vaccine: COVID19-2
Symptoms: X-ray of pelvis and hip normal
Clinical narrative: Discharge Provider: MD Primary Care Provider: DO Admission Date: 12/11/2022 Discharge Date: Dec 14, 2022 COVID positive Date 12/12/2022 PRESENTING PROBLEM: Weakness [R53.1] Failure to thrive in adult [R62.7] Low blood glucose measurement [E16.2] COVID-19 [U07.1]   HOSPITAL COURSE: Patient is a 65-year-old male with a past medical history of coronary artery disease s/p PCI in 2019, pulmonary embolism, T2 Diabetes, diabetic neuropathy, Parkinson's disease, stage 3 chronic kidney disease, GERD who presented from an outside living facility after episodes of hypoglycemia and a witnessed fall without loss of consciousness.   On arrival to the emergency department, he was found to be febrile with a temperature of 38.3°.  Glucose was low at 66, left otherwise within normal limits.  He was without leukocytosis.  Imaging, including pelvis x-ray, chest x-ray, and head CT were negative without any signs of acute abnormalities. On routine screening he was found to be positive for COVID, and was subsequently admitted to medicine for management of hypoglycemia in the setting of COVID infection.   Patient's hypoglycemia was thought to be due to poor oral intake, and he was started on a D5 LR infusion.  After approximately 12 hours, his blood sugars normalized in the mid 150s to 200s, and the infusion was subsequently stopped.  Patient did have intermittent episodes of confusion and hallucinations throughout his hospital stay.  Spoke with patient's son, who requested discontinuation of Artane, who stated he had given patient hallucinations and confusion in the past.  Despite discontinuation, patient continued to have persistent episodes of confusion, agitation, and hallucination.  He received p.r.n. Seroquel during these episodes.  It was arranged for him to return to his care facility despite his COVID 19 positive status, and he was subsequently discharged with plans for PCP and neurology follow-up.
Age: 37.0
Sex: F
Vaccine: COVID19-2
Symptoms: Underdose
Clinical narrative: half dose was given
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Vaccine vial was stored at longer than recommended time post puncture (28 days)
Age: 69.0
Sex: M
Vaccine: FLU4
Symptoms: Agonal respiration, Cardioversion, Cyanosis, Death, Pulse abnormal
Clinical narrative: 12/3 pt went to ED d/t SOB, sore throat, body aches, testing positive for COVID in am and one day of continuous pain radiating down the arm. PMH: CA, DM, HTN, high cholesterol. Cardiology consulted d/t STEMI and pt taken to cath lab. Pt had coronary angio, left heart cath, mechanical thrombectomy, coronary stents placed, intravascular imaging with IVS and TR band to the right radial artery by Dr.. Pt started in Brilinta. Pt admitted to ICU thereafter.  12/5 Plan transfer out of ICU, wean oxygen dc home.   12/6 around 4PM, Pt ready for dc on covid isolation, son waiting downstairs to take pt home. RN stated pt was getting dressed.   Nursing staff noticed via camera pt on the floor. Staff donned PPe and entered room where pt was on the floor by the window. Cyanotic, agonal breathing with thready pulse.  Pt without IV access. CPR initiated.  Meds given, defibrillator.   No ROSC.   Pt passed away.  pronounced on 12/6/22 at 1715 Patient's family decline autopsy I do not have information to link death to vaccine, but reporting due to proximity of dose administered and time of code. pt has received flu vaccine in the past with no reported allergies
Age: 69.0
Sex: M
Vaccine: FLU4
Symptoms: Resuscitation
Clinical narrative: 12/3 pt went to ED d/t SOB, sore throat, body aches, testing positive for COVID in am and one day of continuous pain radiating down the arm. PMH: CA, DM, HTN, high cholesterol. Cardiology consulted d/t STEMI and pt taken to cath lab. Pt had coronary angio, left heart cath, mechanical thrombectomy, coronary stents placed, intravascular imaging with IVS and TR band to the right radial artery by Dr.. Pt started in Brilinta. Pt admitted to ICU thereafter.  12/5 Plan transfer out of ICU, wean oxygen dc home.   12/6 around 4PM, Pt ready for dc on covid isolation, son waiting downstairs to take pt home. RN stated pt was getting dressed.   Nursing staff noticed via camera pt on the floor. Staff donned PPe and entered room where pt was on the floor by the window. Cyanotic, agonal breathing with thready pulse.  Pt without IV access. CPR initiated.  Meds given, defibrillator.   No ROSC.   Pt passed away.  pronounced on 12/6/22 at 1715 Patient's family decline autopsy I do not have information to link death to vaccine, but reporting due to proximity of dose administered and time of code. pt has received flu vaccine in the past with no reported allergies
Age: 78.0
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect dose administered, Product preparation issue
Clinical narrative: she was given a pediatric dose undiluted of 0.3ml, md was call and patient is fine.
Age: 55.0
Sex: F
Vaccine: COVID19-2
Symptoms: Aura, Condition aggravated, Dreamy state, Partial seizures
Clinical narrative: Prior to getting the shot, I had only ever experienced a single episode of seizure.  Since getting the shot, I have experienced 4 episodes of nearly all day focal seizures (where I never lose consciousness, nor the memory of events, and I seem to slip in and out of the focal seizures - in a dream like state with heightened awareness- but no sensory experiences - like smell, taste, etc... during the period I'm actually in aura/dream state).
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Acute kidney injury, COVID-19, COVID-19 pneumonia, Death, Dyspnoea
Clinical narrative: MODERNA COVID VACCINE 3RD DOSE GIVEN 12/30/21, LOT #013H21B; pt to ED with worsening SOB x 1 wk; found to be positive for COVID; placed on BiPAP; AKI; given ABX; respiratory status worsened requiring intubation with mechanical ventilation; ICU; sepsis; COVID pneumonia; thrombocytopenia; transfusion given pt's condition continued to decline; poor prognosis; pt passed away in the hospital
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Endotracheal intubation, General physical health deterioration, Intensive care, Mechanical ventilation, Positive airway pressure therapy
Clinical narrative: MODERNA COVID VACCINE 3RD DOSE GIVEN 12/30/21, LOT #013H21B; pt to ED with worsening SOB x 1 wk; found to be positive for COVID; placed on BiPAP; AKI; given ABX; respiratory status worsened requiring intubation with mechanical ventilation; ICU; sepsis; COVID pneumonia; thrombocytopenia; transfusion given pt's condition continued to decline; poor prognosis; pt passed away in the hospital
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Sepsis, Thrombocytopenia, Transfusion
Clinical narrative: MODERNA COVID VACCINE 3RD DOSE GIVEN 12/30/21, LOT #013H21B; pt to ED with worsening SOB x 1 wk; found to be positive for COVID; placed on BiPAP; AKI; given ABX; respiratory status worsened requiring intubation with mechanical ventilation; ICU; sepsis; COVID pneumonia; thrombocytopenia; transfusion given pt's condition continued to decline; poor prognosis; pt passed away in the hospital
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test normal, COVID-19, Chest X-ray normal, Fatigue, Influenza
Clinical narrative: I thought I was getting a cold. I was so tired. I tested positive for COVID-19 on October 02, 2022, and it was positive. I had a telehealth visit with the nurse practitioner. The symptoms I had were that of pneumonia. I physically went to see the doctor on November 13, 2022, and they checked my blood oxygen level which was really low around 88. They had the medical staff personnel to take me to the emergency room in a wheelchair. They did a flu test and I tested positive for the B strain of flu. They admitted me and I was taking TAMIFLU, amoxicillin, and steroids via IV. I was on 2 liters of oxygen and given a generic form of ROBITUSSIN. I was hospitalized for 6 days. When I was discharged, I was prescribed oxygen which I took for about a week and a half. I was placed on a machine to determine how much oxygen I was using at night and if it's within normal levels, they will pick up the oxygen. I was placed in isolation due to the flu virus.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza B virus test positive, Nasopharyngitis, Oxygen saturation decreased, SARS-CoV-2 test positive, Wheelchair user
Clinical narrative: I thought I was getting a cold. I was so tired. I tested positive for COVID-19 on October 02, 2022, and it was positive. I had a telehealth visit with the nurse practitioner. The symptoms I had were that of pneumonia. I physically went to see the doctor on November 13, 2022, and they checked my blood oxygen level which was really low around 88. They had the medical staff personnel to take me to the emergency room in a wheelchair. They did a flu test and I tested positive for the B strain of flu. They admitted me and I was taking TAMIFLU, amoxicillin, and steroids via IV. I was on 2 liters of oxygen and given a generic form of ROBITUSSIN. I was hospitalized for 6 days. When I was discharged, I was prescribed oxygen which I took for about a week and a half. I was placed on a machine to determine how much oxygen I was using at night and if it's within normal levels, they will pick up the oxygen. I was placed in isolation due to the flu virus.
Age: 3.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Pt received a covid vaccine BUD. Vaccine expired on 7/7/22 and was given to pt on 7/19/22
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Vaccine vial stored at longer than recommended time post puncture (28 days)
Age: 21.0
Sex: F
Vaccine: MMR
Symptoms: Exposure during pregnancy
Clinical narrative: About 3 months pregnant. MMR vaccine was give SQ on 12/20/22
Age: 85.0
Sex: M
Vaccine: FLUA4, FLUA4
Symptoms: Extra dose administered
Clinical narrative: patient had one dose of influenza vaccine administered on 10/26/2022 . Patient did not recall and second dose was given on 12//19/2022. Patient denied feeling ill, short of breath, dizzy, with fever or any ill symptoms.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Respiratory disorder, SARS-CoV-2 test positive, Sinus disorder
Clinical narrative: Started having respiratory and sinus issues; took a Home COVID-19 test and it was positive; Called Doctor and was prescribed Paxlovid and Hydrocodone-Chlorphen; Finished course of medications; Retested for COVID-19 14 days later and was negative; Still has a bad cough.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Vaccine vial stored longer than recommended time post puncture (28 days)
Age: 61.0
Sex: M
Vaccine: COVID19-2
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: I contracted Covid on 12/09/22 in what has been described to me by the CDC representative as a breakthrough case that needed to be reported. I did not have any adverse reactions to any of the 4 vaccines and boosters.  I had the shot administered by Pharmacy on 12/2/22 (third booster), tested positive for Covid on 12/9/22, and had my doctors appointment and prescribed Paxlovid on 12/11/22 at Urgent Care.
Age: 0.17
Sex: F
Vaccine: DTAPIPVHIB
Symptoms: Expired product administered, No adverse event
Clinical narrative: THe vaccine expired on 12/5/2022 and was given to patient on 12/20/22. No symptoms or side effects
Age: 2.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient received Covid vaccine BUD. Vaccine expired on 7/7/22 and was given to py on 7/21/22
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Sneezing
Clinical narrative: I received the second dose of the Moderna COVID-19 vaccine on 3/1/2021. On 8/12/2021, I began sneezing a lot. This lasted for about a day or two, and then it was over. I went to the doctor's office to undergo a COVID-19 rapid test, and the result was positive. After that, I just went home and self-isolated for about 10 days.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Vaccine vial stored at longer than recommended period of time post puncture (28 days)
Age: 71.0
Sex: M
Vaccine: COVID19-2, FLUA4
Symptoms: Dizziness, Dyspnoea, Myocardial infarction, Myocardial necrosis marker increased
Clinical narrative: Pt received Pfizer bivalent and fluad quad on 12/17/22. Pt called on 12/20/22 stating on 12/18/22 pt awoke feeling dizzy and shortness of breath. Pt went to urgent care oxygen levels were normal but cardiac enzyme were "off" and thus told he may have suffered a heart attack. the urgent care suggested doing a cat scan but did not conduct it because pt has stage 3 kidney disease. Pt proceeded to visit hospital, also cat scan not conducted due to stage 3 kidney disease and diabetic. Upon reassessing enzyme levels were normal and after 6 hours of observation pt was released from hospital. On 12/20/22 pt states he feels better today.
Age: 36.0
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered, Interchange of vaccine products
Clinical narrative: Patient had rec'd one dose of Monovalent Moderna. Patient was then given Pfizer Bivalent dose.  Did not complete primary series.
Age: 57.0
Sex: M
Vaccine: COVID19-2
Symptoms: Ear discomfort, Ear infection, Otorrhoea, SARS-CoV-2 test negative
Clinical narrative: I had severe blockage and infection in my left ear producing green mucous initially treated with 150mg Amoxicillin the upon returning treated with 250mg Augmentin and steroids with improvement at the time of this report.
Age: 68.0
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: Patient who is an adult was given 0.25mL of the Moderna Bivalent COVID booster vaccine, which is less than the authorized dose of 0.50mL.  No adverse events were noted at the time of the administration.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Acute kidney injury, COVID-19, Cardiac arrest, Confusional state, Death
Clinical narrative: pt had a positive COVID test in SNF on 7/4/22; pt brought to ED via EMS with decreased UOP, AKI, low BP, increased confusion; pt's condition continued to deteriorate requiring intubation; suffered cardiac arrest; CPR done; pt has permanent pacemaker; husband decided on comfort care and pt passed away in the hospital
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Endotracheal intubation, General physical health deterioration, Hypotension, Resuscitation, SARS-CoV-2 test positive
Clinical narrative: pt had a positive COVID test in SNF on 7/4/22; pt brought to ED via EMS with decreased UOP, AKI, low BP, increased confusion; pt's condition continued to deteriorate requiring intubation; suffered cardiac arrest; CPR done; pt has permanent pacemaker; husband decided on comfort care and pt passed away in the hospital
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Urine output decreased
Clinical narrative: pt had a positive COVID test in SNF on 7/4/22; pt brought to ED via EMS with decreased UOP, AKI, low BP, increased confusion; pt's condition continued to deteriorate requiring intubation; suffered cardiac arrest; CPR done; pt has permanent pacemaker; husband decided on comfort care and pt passed away in the hospital
Age: 10.0
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect dose administered
Clinical narrative: dose was administered 0.5ml instead of 0.25ml
Age: 65.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, Cough, Fatigue, Oropharyngeal pain, Oxygen saturation decreased
Clinical narrative: I woke up with a significant sore throat on 12/13/2022. I tested negative for COVID-19 that day. I had a very fitful night of sleep that night with lots of body aches. When I woke up the next morning on 12/14/2022, I had a fever of around 100 degrees, and I tested positive for COVID-19. I had minimal coughing and very little postnasal drip. I had a virtual visit with my doctor on 12/14/2002. She reviewed my symptoms and decided to prescribe me Paxlovid. On Thursday morning, my oxygen saturation dropped at 91% and I was running a fever of 100.7 even while on 1 gram of Tylenol, so I began taking the Paxlovid on 12/15/2022. I finished my prescription on 12/19/2022. By 12/18/2022, I was feeling a little fatigued, but otherwise normal. I had Tessalon pearls from a previous illness, I took two on Friday, and again on Saturday. I tested negative for COVID-19 yesterday and confirmed with an additional negative result this morning.
Age: 65.0
Sex: F
Vaccine: COVID19-2
Symptoms: Pain, Pyrexia, SARS-CoV-2 test positive, Sleep disorder, Upper-airway cough syndrome
Clinical narrative: I woke up with a significant sore throat on 12/13/2022. I tested negative for COVID-19 that day. I had a very fitful night of sleep that night with lots of body aches. When I woke up the next morning on 12/14/2022, I had a fever of around 100 degrees, and I tested positive for COVID-19. I had minimal coughing and very little postnasal drip. I had a virtual visit with my doctor on 12/14/2002. She reviewed my symptoms and decided to prescribe me Paxlovid. On Thursday morning, my oxygen saturation dropped at 91% and I was running a fever of 100.7 even while on 1 gram of Tylenol, so I began taking the Paxlovid on 12/15/2022. I finished my prescription on 12/19/2022. By 12/18/2022, I was feeling a little fatigued, but otherwise normal. I had Tessalon pearls from a previous illness, I took two on Friday, and again on Saturday. I tested negative for COVID-19 yesterday and confirmed with an additional negative result this morning.
Age: 64.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: COVID-19, Chest discomfort, Cough, Malaise, SARS-CoV-2 test positive
Clinical narrative: I started to feel unwell on 12/14/2022. On 12/15/2022, I started to have a fever and I was experiencing chest heaviness as well. I sent a note to my doctor's office that I tested positive for COVID-19. I went to the pharmacy to pick up a prescription for Paxlovid. I spoke with the Hospital Covid Nurse and she said that she would send the information to my GP. The Paxlovid helped me tremendously. I have not had a fever since 12/17/2022, but I still have a cough every now and then. I am still testing positive.
Age: 16.0
Sex: F
Vaccine: MENB, MNQ
Symptoms: Fall, Feeling abnormal, Hypertension, Tremor
Clinical narrative: after receiving Menatra and Trumemba pt was sitting in room with mom and stated she didn't feel right, then eyes closed and fell to side onto medical table pt was sitting on, mom reports upper and lower b/l shaking of extremities, all lasting < 20-30seconds. no color change. pt came too before I entered the room and cool compress applied, and advised to drink water. HR and BP rechecked, BP slight high, rechecked again in 5mins and nl for pt. nl heart physical exam. pt reports feeling completely normal prior to leaving office and spent another 15mins in office to evaluate finger that she also wanted PE clearance for at time.
Age: 35.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Burning sensation, Erythema, Pruritus, Urticaria
Clinical narrative: November 22, 12 days after vaccine: Itchy all over, hives appearing randomly on stomach, back, neck, arms, legs, feet, palms, everywhere! Bought OTC cortisone cream to help with itching. Progressively got worse. December 1st it was unbearable and nothing was working, left work early to go to facility and get diagnosed "unknown cause of hives" prescribed Triaminolone Acetonide Cream  to apply where hives breakout to ease the itch/burn & 6-day pill pack, Methylprednisolone which I started taking on December 2nd. Still had random hives entire time taking the steroid pill, but they were less fierce. Hives would appear randomly throughout the day, no specific time or place on my body, no specific food agitations or stressors to set it off.  December 5, Dermatologist apt that recommended Allegra 180mg in AM and Xyzal 5mg in PM, switch everything in house to free-and-clear, (which I already had done). Not being a person to take medications regularly, taking two types right away scared me, so I started with 1 Allegra, 180mg in the AM. Seems to work throughout the day, with hives appearing in the evening, but not to the point where I feel I need to take additional medicine, I just go to bed most nights and then take Allegra again when I wake up, hives being  there every morning as well. Have had several reactions to high histamine foods: Dec 7th: Pealing an orange my hands and face turned bright red, Dec 8: cutting cabbage my hands, arms and stomach broke out in hives, Dec 9: eating peanuts, my chin turned beat red. I have been avoiding foods known to be high in histamine until I am able to get further testing done.
Age: 62.0
Sex: M
Vaccine: COVID19-2
Symptoms: COVID-19, Cough, Nasopharyngitis, SARS-CoV-2 test positive, Sinus operation
Clinical narrative: We were coming back from a trip; I got what I thought was a common cold. sinus drainage, cough. I took a home COVID-19 test that came back positive. I called my MD and had a telehealth visit, found that I was one day too late to get the Paxlovid. I was prescribed antibiotics and benzonatate to help with the cough. I cannot seem to get rid of this cough.
Age: 43.0
Sex: M
Vaccine: COVID19-2
Symptoms: Biopsy skin, Blood test, Cutaneous vasculitis, Pain in extremity, Rash
Clinical narrative: Extremely sore arm for 2 weeks.  Developed rash approx 12-13 days after vaccination.  Rash continued to worsen and was diagnosed with Cutaneous Leukocytoclastic Vasculitis.  Have been having ongoing doctor's visits ever since.  Three months later, the rash has covered limbs and trunk.
Age: 43.0
Sex: M
Vaccine: COVID19-2
Symptoms: X-ray
Clinical narrative: Extremely sore arm for 2 weeks.  Developed rash approx 12-13 days after vaccination.  Rash continued to worsen and was diagnosed with Cutaneous Leukocytoclastic Vasculitis.  Have been having ongoing doctor's visits ever since.  Three months later, the rash has covered limbs and trunk.
Age: 79.0
Sex: M
Vaccine: COVID19-2
Symptoms: Blood glucose increased, Chest discomfort, Tremor
Clinical narrative: Client had chest tightness and Shakiness 2 minutes after vaccine given..  Benadryl 25mg administered.  Client recovered to baseline within 30 minutes and released by physician to home
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Wrong technique in product usage process
Clinical narrative: Vaccine vial stored at longer than recommended period of time post puncture (28 days)
Age: 1.25
Sex: M
Vaccine: TDAP
Symptoms: No adverse event, Wrong product administered
Clinical narrative: He received the Tdap and was supposed to receive the Dtap . There have not been any reactions at this time.
Age: 99.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, COVID-19 pneumonia, Death, Dyspnoea
Clinical narrative: pt had a positive COVID test on 7/4/22 and was in the hospital with COVID pneumonia and respiratory failure after a fall; dc'd to SNF; 7/15/22 pt back to ED with increasing dyspnea; respiratory failure; placed on BiPAP; another positive COVID test; pt made slow improvement then became weaker with worsening hypoxia; family transitioned pt to comfort care and he passed away in the hospital